FDA Recall United States Terminated Historical recordClass II
Improper Goods
- Product
- Lemon Ginger Syrup, packaged in 100 mL or 250 mL glass bottl…
- Published
- February 21, 2018
- Distribution
- were distributed in CA, MN, MO, NC, NY,…
Public Health Trace republishes official recall, outbreak, and surveillance data from CDC, FDA, USDA, WHO, and other public sources. It is an independent information service, not a medical provider, and not a substitute for professional medical advice or your local public health department's own guidance.
Please review the following before continuing:
Policy version 2026-07-21, effective July 21, 2026.
United States
TerminatedClass II
Hibiscus Lavender Syrup is recalled because the internal fill temperature noted on production records was below 165¿F.
| Product description | UPC | Quantity | Lot / code information |
|---|---|---|---|
| Hibiscus Lavender Syrup, packaged in 100 mL or 250 mL glass bottle. 100 mL bottle has UPC 8 53142 00505 7. 250 mL bottle has UPC 8 53142 00507 1. These bottles are also sold in the following cocktail kits: -Portland Pony -Dark and Stormy -Whiskey Ginger Smash -Sun Hat -Hibiscus Margarita The label is read in parts: "***RAFT BOTANICALS HIBISCUS LAVENDER COCKTAIL + SODA SYRUP***Slow-brewed in Portland, Oregon***100 ml (3.4 FL OZ)***Ingredients: Organic Cane Sugar, Water, Organic Hibiscus Flowers, Organic Lavender Flowers***Improper Goods, LLC 16313 NE Cameron Blvd. Portland, OR 97230***". | Not published in this source record | 191/100 mL bottles and 21/250 mL bottles | 000917 USE BY 012019 |
This recall shares FDA event ID 79109 with 1 other product entry in Public Health Trace.
FDA Recall United States Terminated Historical recordClass II
Responsible company: Improper Goods
FDA Recall United States Terminated Historical recordClass II
A map highlighting the states named in the source's distribution description.
Shading reflects state-level totals only, as published by the source. It does not imply county-level or point-level precision.
| State | Distributed |
|---|---|
| California | 1 |
| Minnesota | 1 |
| Missouri | 1 |
| North Carolina | 1 |
| New York | 1 |
| Ohio | 1 |
| Oregon | 1 |
| Washington | 1 |
| Virginia | 1 |
States shown are extracted from the source's free-text distribution description above; a narrative description (e.g. "distributed nationwide") may not list individual states to extract.
View FDA enforcement record -- the specific openFDA record this summary was built from.
No separate FDA public notice was found for this enforcement record. The information below comes from FDA's Recall Enterprise System through openFDA.
FDA Enforcement Reports -- FDA's general, official recall and enforcement information.
View raw source data -- the machine-readable record this page's information was built from.
Retrieved by Public Health Trace:
A situation in which use of or exposure to a product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote.
According to FDA, this recall's status is "Terminated." Always confirm the current status using the source links below, since status can change after Public Health Trace last retrieved this record.
Follow the instructions published by the responsible agency (see the source links below) -- recall guidance (e.g. dispose of the product, return it for a refund, or check for a specific lot number) varies by recall and is set by that agency, not by Public Health Trace.
The source links below, published by FDA, are the authoritative record for this recall, including any updates issued after this summary was retrieved.
This summary is based on the official source record referenced above. Public Health Trace does not state that any company or product is unsafe beyond what the official source has published. Read the full medical disclaimer.